VVOS

Vivos Therapeutics, Inc. - Common Stock (VVOS)

About Vivos Therapeutics, Inc. - Common Stock (VVOS)

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.

Details

Daily high

$2.90

Daily low

$2.55

Price at open

$2.70

52 Week High

$6.28

52 Week Low

$1.97

Market cap

14.6M

Dividend yield

0.00%

Volume

502,217

Avg. volume

135,524

P/E ratio

-1.29

Vivos Therapeutics, Inc. - Common Stock News